Almitas Capital »

Atea Pharmaceuticals shares owned by Almitas Capital

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Almitas Capital from 13F filings

Historical chart of Almitas Capital investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Almitas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Almitas Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.6M 1.4M 3.35
2024-06-30 $4.3M 1.3M 3.31

More positions owned by Almitas Capital

Fidelity Wise Origin Bitcoin Fund SHS (FBTC)
BlackRock Health Sciences Term Trust Com Shs (BMEZ)
Nuveen PA Investnt Quality Municipal (NQP)
Miller/Howard High Dividend Fund Com Shs Ben In (HIE)
BlackRock Municipal 2030 Target Term Trust Com Shs Ben In (BTT)
Tortoise Midstream Energy M (NTG)
Mainstay Definedterm Mn Opp (MMD)
Bny Mellon Mun Income (DMF)
Pgim Short Dur Hig Yld Opp F (SDHY)
Design Therapeutics (DSGN)
Eaton Vance New York Municipal Bond Fund (ENX)
Amylyx Pharmaceuticals (AMLX)
Western Asset Invest. Grade Defined Opp (IGI)
BlackRock ESG Capital Allocation Term Trust Shs Ben Int (ECAT)
Tortoise Pipeline & Energy F (TTP)

View all positions for Almitas Capital

Top funds holding Atea Pharmaceuticals

BlackRock
BlackRock
BML Capital Management
EcoR1 Capital
Vanguard Group
Tang Capital Management
Bain Capital Life Sciences Investors
Geode Capital Management
State Street Corporation
Almitas Capital
Renaissance Technologies
Acadian Asset Management
Dimensional Fund Advisors
Northern Trust
Charles Schwab Investment Management

View all funds holding Atea Pharmaceuticals